Sanyou Bio Launches oneClick+ Antigen Platform for Tumor Immunotherapy

Sanyou Bio, based in China, has launched the oneClick+ antigen platform to support tumor immunotherapy research and development. This innovative platform provides a comprehensive one-stop solution that includes antigen analysis and personalized preparation of antigens for researchers. It showcases high-quality annotation of protein sequences, offering detailed information about properties such as amino acid sequences, isoelectric points, and subcellular localization, which simplifies the antigen analysis process. By providing access to an extensive dataset, Sanyou Bio aims to address the challenges researchers face in protein expression and antigen analysis. The oneClick+ platform facilitates a user-friendly experience, allowing scientists to initiate custom antigen designs simply by inputting the Uniprot ID of the protein they are interested in. Additionally, the platform offers a feature to evaluate the difficulty of protein preparation, grounded in data analysis of over 56,000 proteins extracted from the Uniprot database. Furthermore, the platform generates detailed reports that include key physicochemical properties of antigens, making it easier for scientists to extract relevant information without facing overwhelming data. The service also includes free reports for users who sign up, promoting a collaborative environment in scientific research. This launch signifies a step forward in supporting researchers in the field of immunotherapy through advanced technological solutions, enhancing the efficiency and accuracy of antigen preparation in scientific investigations.